Navigation Links
Sunesis Pharmaceuticals Reports Positive Data From Studies of Two,Anti-Cancer Agents, SNS-595 and SNS-032, at the 12th Congress of,the European Hematology Association

it."

SNS-032 is a potent, selective inhibitor of CDKs 2, 7 and 9 that inhibits both cell cycle progression and transcription of anti-apoptotic signals key to the survival of B-cell malignancies. SNS-032 is currently being studied in a Phase 1 dose-escalation safety trial in patients with B-cell malignancies, including chronic lymphocytic leukemia, mantle cell lymphoma and multiple myeloma. Sunesis plans to present preliminary data from this ongoing Phase 1 trial by year's end.

Data on SNS-595 and SNS-032 were presented at the 12th Congress of European Hematology, organized by The European Hematology Association (EHA) on Saturday, June 9, 2007 in two poster sessions:

    -- Abstract #0489: "Pharmacokinetic/Pharmacodynamic Correlation with

       Responses in a Phase 1 Study of Patients with Relapsed/Refractory Acute

       Leukemias Treated with SNS-595"

    -- Abstract #0742: "SNS-032 Exhibits Dose-Dependent Mechanism-Based

       Inhibition of CDK7 and CDK9 in Peripheral Blood Mononuclear Cells from

       Patients with Advanced Cancers Treated in an Ongoing Phase 1 Trial"

About Sunesis' Oncology Programs

Sunesis has built a rich portfolio of product candidates in oncology focused on novel pathways and targets, including inhibition of the cell-cycle and survival signaling. Sunesis is currently conducting Phase 2 clinical trials in lung and ovarian cancer and a Phase 1 clinical trial in acute leukemias for its lead compound, SNS-595. SNS-032, a selective inhibitor of cyclin-dependent kinases 2, 7 and 9, is being evaluated in Phase 1 clinical trials in B-cell malignancies and in advanced solid tumors. The company's Aurora kinase inhibitor, SNS-314, is expected to begin Phase 1 clinical trials in mid-2007. In addition, Sunesis is developing novel small molecule inhibitors of Raf kinase and other oncology kinases in collaboration with Biogen Idec.

About Sunesis Pharmaceuticals

Sunesis is a clinical-stage biop
'"/>




Page: 1 2 3 4 5 6

Related medicine technology :

1. Sunesis Pharmaceuticals to Present at the C. E. Unterberg, Towbin Emerging Growth Conference
2. Sunesis Pharmaceuticals to Present Data at the 12th Congress of the European Hematology Association
3. Sunesis Presents Data Supporting SNS-032s Potential Anticancer Activity in Multiple Myeloma at the American Association for Cancer Research Meeting
4. Sunesis Pharmaceuticals to Present Data at the Annual Meeting of the American Association for Cancer Research
5. Sunesis Pharmaceuticals Presents SNS-314 Aurora Kinase Inhibitor Data Showing Broad Anti-Tumor Activity, Dosing Flexibility
6. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
7. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
8. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
9. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
10. EPIX Pharmaceuticals to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
11. Pro-Pharmaceuticals Updates Progress of Clinical Trials & Davanat 505 (b)(2) Filings
Post Your Comments:
(Date:4/21/2015)... , April 21, 2015  St. Vincent Healthcare ... patient care. Already following strict disinfection routines, St. ... SmartUVC to eliminate harmful germs, like Ebola, methicillin-resistant ... norovirus that can infect patients during their hospital ... Logo - http://photos.prnewswire.com/prnh/20150420/199749LOGO ...
(Date:4/21/2015)... 2015 Legal cannabis markets, products ... at a rapid pace over the next five years ... services for indoor/outdoor cultivators and new cannabis products for ... (OTC: SRNA), Totally Hemp Crazy Inc. (OTC: THCZ), Medical ... 22 nd Century Group, Inc. (NYSE: XXII ...
(Date:4/21/2015)... -- IntelliQuit™, the world,s first smartphone breathalyzer for smokers, was selected to present as a finalist at ... on Wednesday April 22.  Photo ... ... ... Thirty percent (30%) of all cardiovascular disease is caused by smoking. The ...
Breaking Medicine Technology:St. Vincent Healthcare Deploys Germ-Killing Robot to Prevent Infection, Protect Patients During Hospital Visits 2St. Vincent Healthcare Deploys Germ-Killing Robot to Prevent Infection, Protect Patients During Hospital Visits 3New Technology, Innovative Products & State-of-the-Art Equipment in the Legal Cannabidiol Industries Continue to Provide Growing Revenue Opportunities 2New Technology, Innovative Products & State-of-the-Art Equipment in the Legal Cannabidiol Industries Continue to Provide Growing Revenue Opportunities 3New Technology, Innovative Products & State-of-the-Art Equipment in the Legal Cannabidiol Industries Continue to Provide Growing Revenue Opportunities 4New Technology, Innovative Products & State-of-the-Art Equipment in the Legal Cannabidiol Industries Continue to Provide Growing Revenue Opportunities 5New Technology, Innovative Products & State-of-the-Art Equipment in the Legal Cannabidiol Industries Continue to Provide Growing Revenue Opportunities 6New Technology, Innovative Products & State-of-the-Art Equipment in the Legal Cannabidiol Industries Continue to Provide Growing Revenue Opportunities 7IntelliQuit World's First Smartphone Breathalyzer for Smokers to Present to American Heart Association Innovation Investment Forum 2IntelliQuit World's First Smartphone Breathalyzer for Smokers to Present to American Heart Association Innovation Investment Forum 3
(Date:4/21/2015)... 2015 Patients seeking surgical treatment for ... choice for receiving treatment at a nationally accredited program ... quality of care in the greater Tampa area. ... center has been accredited as a Comprehensive Center under ... Program (MBSAQIP), a joint program of the American College ...
(Date:4/21/2015)... 21, 2015 Henry Mayo Newhall Hospital, ... Care Exchange to automatically send continuation of care ... to further improve communication with clinics and other ambulatory ... Alert solution. , “Provider Alert will enable ... patient information they need to provide continuing care in ...
(Date:4/21/2015)... “ ZeroWire ” was featured on ... takes a look at the latest and coolest technology ... special reporter for NewsWatch and a technology expert, conducted ... a security system and lifestyle management hub. , According ... 2 million burglaries in 2010. It goes without saying ...
(Date:4/21/2015)... BC (PRWEB) April 21, 2015 Angelo’s ... complimentary pick-up and delivery for clients that avail the ... Surrey by Angelo’s is done with hi-tech equipments, making ... for customers. They use all natural, high pressure steam ... well as hand washing for area rugs made with ...
(Date:4/21/2015)... Lowcostcarinsuranceprice.com has released a new blog post explaining how ... , SUVs are large vehicles that fare well in ... a smaller regular car shows that passengers from the first ... safer in crashes, but these large vehicles may be unstable ... It is now possible to find low cost car insurance ...
Breaking Medicine News(10 mins):Health News:Florida Hospital Tampa Achieves National Accreditation from the Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program 2Health News:Florida Hospital Tampa Achieves National Accreditation from the Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program 3Health News:Florida Hospital Tampa Achieves National Accreditation from the Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program 4Health News:Henry Mayo Newhall Hospital to Improve Ambulatory Information Sharing with Summit Healthcare's Summit Provider Alert 2Health News:A Leader in Home Security was Featured on NewsWatch Television 2Health News:Angelo’s FabriClean Now Offers Area Rug Cleaning in South Surrey with Complimentary Pick-Up and Delivery 2Health News:Auto Insurance Quotes For SUVs Are Available Online 2
... Treatment that increases brain levels of an important regulatory ... characterizes Huntington,s disease (HD) and other neurodegenerative disorders. ... Nature Medicine , a Massachusetts General Hospital (MGH)-based research ... a family of enzymes called sirtuins, in the brain ...
... The busy holiday season may disrupt many people,s daily routines, ... to remember to look after your teeth, an expert advises. ... treats and drink alcoholic beverages more than usual," Dr. George ... an academy news release. "Additionally, with their busy schedules ...
... Accelerated partial breast irradiation using brachytherapy (APBIb) for ... increasing over the last several years in the ... (WBI), according to a study published December 16th ... Cancer Institute . Various types of APBI ...
... , FRIDAY, Dec. 16 (HealthDay News) -- ,Draft recommendations ... trials for medical devices were released Friday by the ... size, diet, social and cultural factors, and types of ... medical products and devices than men, according to the ...
... scientists at the University of California, San Francisco has ... disorder called PKD/IC, or "paroxysmal kinesigenic dyskinesia with infantile ... disorders in older children. The study involved clinics ... London and Istanbul and may improve the ability of ...
... 16 (HealthDay News) -- Chronic pain can hinder communication ... partner,s ability to cope with the pain, according to ... validation of a spouse,s emotions (showing respect and acceptance) ... emotions (showing hostility or no interest) increases emotional distance ...
Cached Medicine News:Health News:Regulatory enzyme overexpression may protect against neurodegeneration in Huntington's disease 2Health News:Dentist Gives Advice to Keep Holiday Smiles Bright 2Health News:Advantages and motivations uncertain behind use of brachytherapy for breast cancer radiotherapy 2Health News:Advantages and motivations uncertain behind use of brachytherapy for breast cancer radiotherapy 3Health News:FDA Seeks to Get More Women Into Trials of Medical Devices 2Health News:UCSF-led team discovers cause of rare disease 2Health News:Spouse's Reaction May Affect Pain Management 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: